Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07265466RecruitingPhase 1
Safety study of JP-1366 with common heart and blood medications
This trial tests how a new drug, JP-1366, interacts with several common heart and blood medications (clopidogrel, aspirin, atorvastatin, and apixaban) in healthy volunteers. It aims to see if the combination is safe and how the drugs affect each other in the body.
Seongnam-si, Gyeonggi-doAges 19–64 - NCT07261644RecruitingPhase 3
Study of a new drug for active ankylosing spondylitis
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07262619RecruitingPhase 1/Phase 2
Study of EIK1005 for advanced solid tumors
This study tests an experimental drug called EIK1005, either alone or combined with another drug (pembrolizumab), for people with advanced solid tumors, especially those with MSI-H or dMMR cancers (tumors that have trouble repairing their DNA). The goal is to see if it can shrink tumors or slow cancer growth.
Los Angeles, CaliforniaAges 18 years+ - NCT07265284RecruitingPhase 3
IBI112 for teens with moderate to severe plaque psoriasis
This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.
Beijing, Beijing MunicipalityAges 12–18 - NCT07267026RecruitingPhase 1
Safety study of the drug SK-09 in healthy adults
This trial tests a new medicine called SK-09 in healthy volunteers to see if it is safe and how the body processes it. The results will help decide the right dose for future studies.
Herston, QueenslandAges 18–55 - NCT07259538RecruitingPhase 1
Safety study of VVN432 nasal spray
This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.
BeijingAges 18–55 - NCT07259889RecruitingPhase 1
CEL001 injection safety study for advanced solid tumors
This trial tests a new injection called CEL001 for people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. The goal is to see if it is safe and find the right dose.
BeijingAges 18 years+ - NCT07264270RecruitingPhase 1
A new injection for long-term sciatica pain
This trial tests a new medicine called C-1101, given as a shot into the spine, to see if it safely reduces pain from chronic sciatica. It is for people who have not gotten enough relief from standard treatments.
Broadmeadow, New South WalesAges 18–65 - NCT06896071Recruiting
A digital mental health program for teens
This trial tests a one-session digital program designed to help New Zealand teens aged 12–14 feel better mentally. It's a simple online tool you can use once during school.
CambridgeAges 12–14 - NCT06890676Recruiting
Dental care in nursing homes to prevent infections and improve health
This study tests whether bringing dental care to nursing home residents can reduce mouth infections, pneumonia, and help control blood sugar in people with diabetes. If you live in a nursing home and are 60 or older, you may be able to join.
Jefferson City, MissouriAges 60–100 - NCT06896942Recruiting
Autism doula program for Black caregivers
This study offers a doula program (a trained support person) to help Black caregivers of young children newly diagnosed with autism. It aims to see if this support improves your experience and your child's development.
Cincinnati, OhioAges 1.5 years–5.9 years - NCT07267156Recruiting
New Dressing After Bunion Surgery
This study tests a new type of bandage or dressing used after bunion (hallux valgus) surgery. It aims to see if this dressing works better than the usual dressing to help your foot heal.
Geneva, Canton of GenevaAges 18 years+ - NCT07263113Recruiting
Gum disease and heart health study
This study looks at whether severe gum disease (periodontitis) is linked to stiffer arteries and higher heart risk. If you have advanced gum disease or healthy gums, you may be able to join to help researchers understand this connection.
NantesAges 40–69 - NCT07262086Enrolling by invitation
Bioactive filling for deep cavities in back teeth
This trial tests a new type of self-hardening tooth-colored filling material that may help repair and protect deep cavities in back teeth. It is looking for people with two molars that need deep fillings, to see if the material stays strong and helpful over time.
Ismailia, IsmaliaAges 21–45 - NCT07260968Recruiting
Better Pumping Workflows to Help Breastfeeding Parents
This study tests a better way to help parents pump breast milk more efficiently. It also looks at how the body makes milk. It may help you breastfeed longer and with less hassle.
Rochester, New YorkAges 18–45 - NCT07261735Recruiting
Custom attachments for clear aligner therapy
This study tests whether custom-made attachment composites improve the effectiveness of clear aligners for treating mild-to-moderate crowding or spacing. It may help you achieve better tooth movement during orthodontic treatment.
Ankara, AnkaraAges Any age - NCT07268170Enrolling by invitationPhase 2/Phase 3
Heart rate control before heart CT scan
This trial tests two medicines to lower heart rate before a cardiac CT scan in adults who need the scan. It is for people whose heart rate is naturally a bit fast (over 65 beats per minute) but not too fast (under 100 bpm).
HerningAges 30–80 - NCT07264439Recruiting
Virtual reality with hypnosis for Alzheimer's patients during hygiene care
This trial tests whether virtual reality headsets showing hypnosis scenes can reduce agitation and resistance during bathing or toileting in people with Alzheimer's disease. It aims to make daily care calmer and less stressful for patients and caregivers.
AmiensAges 18 years+ - NCT07260175RecruitingPhase 2
Ivosidenib maintenance for IDH1-mutated bile duct cancer
This trial tests a targeted pill called ivosidenib for people with a specific type of bile duct cancer (IDH1-mutated) who have completed surgery and chemotherapy. The goal is to see if taking ivosidenib as a maintenance therapy helps keep the cancer from coming back.
AachenAges 18 years+ - NCT07267260RecruitingPhase 2
Vonoprazan to prevent ulcers after variceal banding
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
Lahore, Punjab ProvinceAges 18–75 - NCT07260695RecruitingPhase 4
Odyssey Lens Study for Post-LASIK Cataract Patients
This trial tests a new type of lens implant (Odyssey IOL) for people who have had LASIK surgery and now have cataracts. It aims to see how well the lens works after cataract surgery in both eyes.
Venice, FloridaAges 50 years+ - NCT07268378Enrolling by invitation
Supervision for oncology clinicians by psycho-oncologists
This trial studies whether supervision by a psycho-oncologist (a mental health expert in cancer care) helps doctors and nurses who work in oncology or hematology. It aims to support their well-being and communication skills.
Lausanne, Canton of VaudAges Any age - NCT07262892Recruiting
3D study of jaw widening methods in children
This trial uses 3D imaging to compare two ways of widening the upper jaw in children. It may help your child if they need jaw expansion and haven't had it before.
Istanbul, FatihAges 6–12 - NCT07263295Recruiting
Diaphragm function after shoulder block with long-lasting numbing medication
This study checks how a nerve block for upper arm surgery affects the diaphragm, the muscle that helps you breathe. It uses a long-lasting numbing medicine to see if breathing is affected.
Hangzhou, ZhejiangAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.